We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
LXP Industrial Trust
LXP
$3.53B
| $1.08M | ﹤0.01% |
23,648
| – | – |
|
1027
Integra LifeSciences
IART
$1.36B
| $1.08M | ﹤0.01% |
25,466
| – | – |
|
|
EQC
1028
DELISTED
Equity Commonwealth
EQC
| $1.08M | ﹤0.01% |
44,240
+22,360
| +102% | +$601K |
|
1029
American States Water
AWR
$3.45B
| $1.08M | ﹤0.01% |
13,813
-2,420
| -15% | -$205K |
|
1030
Fluor
FLR
$6.63B
| $1.08M | ﹤0.01% |
43,220
-6,260
| -13% | -$160K |
|
1031
Grand Canyon Education
LOPE
$4.16B
| $1.08M | ﹤0.01% |
13,080
-3,600
| -22% | -$312K |
|
1032
Agilon Health
AGL
$1.58B
| $1.07M | ﹤0.01% |
+1,836
| New | +$1.1M |
|
1033
BARK
BARK
$78M
| $1.07M | ﹤0.01% |
29,536
| – | – |
|
1034
VF Corp
VFC
$5.78B
| $1.07M | ﹤0.01% |
35,893
-527
| -1% | -$22.7K |
|
1035
Trip.com Group
TCOM
$29.1B
| $1.07M | ﹤0.01% |
39,300
+3,000
| +8% | +$78.6K |
|
1036
QuidelOrtho
QDEL
$1.13B
| $1.07M | ﹤0.01% |
14,935
-20,670
| -58% | -$1.85M |
|
1037
Cenovus Energy
CVE
$53.7B
| $1.06M | ﹤0.01% |
63,534
+1,600
| +3% | +$28.4K |
|
1038
Chord Energy
CHRD
$7.61B
| $1.06M | ﹤0.01% |
7,740
+2,030
| +36% | +$260K |
|
1039
ICU Medical
ICUI
$4.15B
| $1.06M | ﹤0.01% |
7,035
| – | – |
|
1040
Federal Realty Investment Trust
FRT
$10.9B
| $1.06M | ﹤0.01% |
11,740
+6,500
| +124% | +$660K |
|
|
COOP
1041
DELISTED
Mr. Cooper
COOP
| $1.05M | ﹤0.01% |
26,060
-1,810
| -6% | -$76.6K |
|
1042
Texas Capital Bancshares
TCBI
$4.26B
| $1.05M | ﹤0.01% |
17,720
| – | – |
|
1043
Sana Biotechnology
SANA
$857M
| $1.04M | ﹤0.01% |
174,141
-130,318
| -43% | -$940K |
|
1044
Cracker Barrel
CBRL
$1.24B
| $1.04M | ﹤0.01% |
11,281
-4,310
| -28% | -$433K |
|
1045
TD Synnex
SNX
$20.2B
| $1.04M | ﹤0.01% |
12,852
| – | – |
|
|
BERY
1046
DELISTED
Berry Global Group, Inc.
BERY
| $1.04M | ﹤0.01% |
24,350
+1,525
| +7% | +$76.6K |
|
1047
Energizer
ENR
$1.47B
| $1.04M | ﹤0.01% |
41,254
| – | – |
|
|
MRUS
1048
DELISTED
Merus
MRUS
| $1.04M | ﹤0.01% |
51,773
+17,669
| +52% | +$422K |
|
1049
Restaurant Brands International
QSR
$26B
| $1.04M | ﹤0.01% |
17,808
| – | – |
|
1050
Kymera Therapeutics
KYMR
$8.71B
| $1.03M | ﹤0.01% |
47,547
+1,130
| +2% | +$29.8K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.